Finarinone's Role in Treating Diabetic Kidney Disease

This chapter explores the efficacy of finerenone as a non-steroidal MRA in treating type 2 diabetes patients with residual albuminuria. It highlights its potential to decrease the risks of chronic kidney disease progression and heart failure, while also addressing the necessity of careful patient monitoring for side effects.